How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/relapsing-forms-of-multiple-sclerosis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Relapsing forms of multiple sclerosis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Relapsing forms of multiple sclerosis (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Relapsing forms of multiple sclerosis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Vumerity	DIROXIMEL FUMARATE	Biogen		Hydroxycarboxylic acid receptor 2	2019-01-01
BRIUMVI	UBLITUXIMAB-XIIY	TG THERAPEUTICS, INC	CD20-directed Cytolytic Antibody [EPC]	B-lymphocyte antigen CD20
Vumerity	Vumerity	University of Nebraska		Nuclear factor erythroid 2-related factor 2, Hydroxycarboxylic acid receptor 2

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Biogen · 1 drug in Relapsing forms of multiple sclerosis
TG THERAPEUTICS, INC · 1 drug in Relapsing forms of multiple sclerosis
University of Nebraska · 1 drug in Relapsing forms of multiple sclerosis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Relapsing forms of multiple sclerosis:

Cite this brief

Drug Landscape (2026). Relapsing forms of multiple sclerosis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/relapsing-forms-of-multiple-sclerosis. Accessed 2026-06-10.

Relapsing forms of multiple sclerosis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing